Health Ministry Revises BA/BE Study Rules: Minimum Sample Size Set at 18 Susmita Roy9 Nov 2025 2:00 PM ISTNew Delhi: In a key regulatory update impacting India's clinical research framework, the Ministry of Health and Family Welfare (MoHFW) has revised its...
Solara Active Pharma Swings to Rs 10.1 Crore Loss in Q2 FY26 Amid Shutdown Impact, Focuses on Deleveraging Susmita Roy6 Nov 2025 2:41 PM ISTNew Delhi: Solara Active Pharma Sciences Limited has reported a consolidated net loss of Rs 10.1 crore for the quarter ended September 30, 2025 (Q2...
Zydus Lifesciences Slapped Rs 3.35 Crore Tax Demand Over CENVAT Credit Parthika Patel29 Sept 2025 10:48 PM ISTNew Delhi: Zydus Lifesciences Limited has informed the stock exchanges that the Commissioner of Central Goods and Services Tax (CGST), Ahmedabad, has...
Zydus Lifesciences Gets CDSCO Panel Nod for Bioavailability Study of Antimalarial Candidate ZY-19489 Parthika Patel25 Sept 2025 3:24 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Investigational New Drugs under the Central Drugs Standard Control Organisation (CDSCO) has...
Alkem Launches Olesoft Trucera Lotion to Repair Skin Barrier, Boost Hydration Parthika Patel20 Aug 2025 2:30 PM IST"In June 2025, Olesoft Lite was recognised by IQVIA as the "Best Launch of the Year" in the face moisturiser category,"Alkem said.
No Ban on Paracetamol, Says Govt; 156 Drug Combos Axed Over Safety Concerns Farhat Nasim7 Aug 2025 7:41 PM ISTNew Delhi: While 156 fixed-dose combinations (FDCs), including some involving Paracetamol, have been banned in public interest, the standalone drug...
AbbVie Eyes USD 1 Billion Buyout of Mental Health Drugmaker Gilgamesh Parthika Patel31 July 2025 10:30 AM ISTBengaluru: Drugmaker AbbVie is in talks to acquire privately-held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about...
GSK Raises Outlook After Q2 Beat, Eyes USD 53.44B Sales by 2031 Parthika Patel31 July 2025 10:15 AM ISTBengaluru: British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after second-quarter sales and earnings...
Govt Panel Makes This Approval Mandatory For New Drug Licenses Farhat Nasim5 July 2025 4:44 PM ISTNew Delhi: Raising serious regulatory concerns, the apex statutory body under the Central Drugs Standard Control Organisation (CDSCO), the Drugs...
Dettol Controversy: Reckitt Settles with Influencer Raj Shamani, But To Proceed Legally Against Dermatologist Farhat Nasim7 May 2025 7:41 PM ISTNew Delhi: Reckitt Benckiser, the company behind Dettol, has informed the Delhi High Court that it has reached a settlement with popular social media...
Ranitidine Under Scanner Again: DTAB, CDSCO Recommend New Safety Study, Tighter Monitoring Farhat Nasim6 May 2025 6:02 PM ISTNew Delhi: Amid continued global concerns over the presence of N-nitrosodimethylamine (NDMA) impurities in ranitidine, the Drugs Technical Advisory...
Not a Nice Time For Nimesulide? DTAB, CDSCO Recommend Stringent Restrictions Farhat Nasim3 May 2025 7:31 PM ISTNew Delhi: Nimesulide, a widely used painkiller in India, is facing renewed regulatory scrutiny over its safety profile, with India's apex drug...
